Owen Mumford introduces 16G safety lancet into Unistik Touch range

Owen MumfordTue 16th Mar 20212 min

New 16G size designed for high volume blood sampling for HCPs and test kit manufacturers producing home sampling kits

Owen Mumford, a global leader in the design, manufacture and advancement of medical technology, today announced it has introduced a 16-gauge (16G) safety lancet for high-volume capillary blood sampling into its leading Unistik product range. The new Unistik® Touch 16G has one-touch activation and Comfort Zone Technology® that minimises the pain of finger sampling.1

The new safety lancet has been designed for healthcare professionals (HCPs) and test kit manufacturers. For HCPs who need to perform higher volume blood sampling on patients for a wide range of tests including blood gas, electrolytes, blood coagulation, total bilirubin and cardiac markers, it can be used in a variety of clinical settings and offers the benefit of fewer punctures for higher blood volumes.

It is also ideally suited for at-home and point of care testing (POCT) kits, making it a convenient choice for test kit inclusion by kit manufacturers who require reduced packaging, bulk order quantities and can benefit from its small form and simple user features.

The Unistik Touch 16G one-touch activation feature requires the user to simply press the device against the sample site. Activated automatically, the needle then retracts into the body of the device, minimising the risk of re-use, pre-analytical errors for multiplex tests, cross infection and needlestick injuries.

“The Unistik Touch range was developed in-house to make sampling more comfortable for patients and easier for HCPs to successfully obtain the right amount of blood first-time,” said Jesper Jonsson, Director of Medical Devices at Owen Mumford. “Our proven pain-minimising technology and simple one-touch activation makes it a very attractive option and the 16G lancet has been developed and priced competitively to ensure the same benefits in patient comfort can be offered within the growing at-home testing and POCT markets. This new solution for high volume blood sampling perfectly complements our portfolio so we can offer the market an even wider choice of safety lancet.”

The Unistik Touch 16G is available in a range of packaging configurations including 100ct, 200ct and bulk volumes. Further educational material has been created in collaboration with HCPs and key opinion leaders to support everyone in achieving reliable test results.

For more information on Unistik Touch 16G go to: https://www.owenmumford.com/en/healthcare-professionals-product/unistik-touch/

1. Melzack, R. and Wall, P. The Challenge of Pain. Harmondsworth, UK: Penguin; 1982, p233.]

Additional Tags: #health #healthcare #Manufacturing

By Jarl Severn Managing Director

Owen Mumford

More in Health

Business Services, Health | Oxfordshire

Newrotex takes new R&D lab space at the Wood Centre for...

Oxford InnovationWed 11th Feb 20264 min

Newrotex, a clinical-stage biotech start-up developing innovative silk-based medical devices for nerve repair, has taken 1,680 sq ft (156 sq m) of manufacturing and R&D laboratory and office space at The Oxford Trust’s Wood Centre for Innovation in Headington, Oxford, as it enters a critical phase of clinical and operational scale-up.

Health, Workplace Wellbeing | Oxfordshire

New B4 Member Introduction: Luka Baggio, Renew Yoga Massage

Renew Yoga MassageFri 9th Jan 20262 min

Hello, I’m Luka Baggio, founder of Renew Yoga Massage, based in Bicester and Weston-on-the-Green. My work is rooted in helping people move, breathe and feel better in their bodies — whether that’s through hot yoga, warm yin, Thai yoga massage, or training future therapists.

Health, People | Oxfordshire

Breaking Free from the Snacking Trap: Practical Solutions for Mindful Eating...

Hall Personal TrainingMon 28th Jul 20256 min

Thanks to Becky Hodgson at Hall Training for this excellent article. B4 Members can also benefit from £25 off Hall’s 30 Day Accelerator – please contact Becky as per the e-mail at the bottom of this article.

From this author

Owen Mumford’s Near-Term and Net-Zero targets approved by the SBTi

Owen MumfordThu 9th May 20242 min

Owen Mumford, a leader in the medical device industry and certified B Corp, has announced that the Science Based Targets initiative (SBTi) has approved its near-term science-based emissions reduction target. The medical device manufacturer has also committed to set long-term emissions reduction targets with the SBTi in line with reaching net-zero by 2045 – 5 years ahead of the UK’s net-zero target.